There are two types of Abstract submission for the ASNOS 2019
Walsh in Asia submissions (for guidelines, please click here.)
Scientific Paper submission
Scientific Paper (including Case Reports and Non-Case Reports)
Scientific paper submission is open for platform or poster presentation.
Scientific papers accepted for platform presentation will be presented during 1 of 2 Free Paper sessions during the ASNOS 2019 congress.
Papers not accepted for platform presentation will be offered the opportunity to be presented as posters.
The presenting author must be a registered participant for the ASNOS 2019 Congress.
SCIENTIFIC PAPER (Case Reports and Non Case Reports) ABSTRACT SUBMISSION GUIDELINES:
Abstracts must be in English.
All abstracts should be submitted online.
Abstracts will be reproduced exactly as submitted. Please edit your abstract carefully to avoid errors and misspellings.
Title: CAPITALIZE the entire title within the area provided. It should be informative, concise, meaningful, as brief as possible, and no longer than 135 characters.
Author(s): Provide the full name of every author, including degrees, but omit titles or institutional appointments. Presenting author’s name should be mentioned first.
Institution(s): Indicate the name and address of the institution(s) where the research work was carried out.
Text: Abstracts should contain adequate and pertinent information describing the contents of the scientific paper. The text should not exceed 300 words (not including Title, Authors, Affiliations, References) and should be arranged in the following format:
FOR CASE REPORTS:
Introduction – Concisely state relevant background information.
Description – Include relevant case data.
Conclusion – Give emphasis on the uniqueness of the case and its key learning points.
FOR NON-CASE REPORTS:
Objective – Concisely state purpose and relevant background information.
Methods – Describe study design, how subjects were selected, and the number of subjects and/or observations included in the study.
Results – State in a logical sequence, include quantitative descriptions and/or comparisons.
Conclusions – State new and/or important feature of the study, and conclusions drawn from it
Abbreviations, acronyms, and symbols should be defined the first time they are used. Place the abbreviation in parentheses after the full word.
Use generic names of drugs.
Proprietary and/or financial interests in any products (or competing products) described in the abstract must be disclosed.
Please check this page regularly for more updates on Scientific submission guidelines. Submission gateway is not yet open. Abstract submission will open sometime in the April 2019.
To know more about submission date deadlines please click here.